Research news

UCLH is one of 13 NHS hospitals running a world-leading study in which hundreds of babies will be tested for over 200 rare genetic conditions. The pioneering study aims to screen up to 100,000 newborns in England.

More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.

A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.

A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.

UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.